Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:2337-2345
Published online before print June 14, 2007, doi: 10.1161/STROKEAHA.107.481838
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/8/2337    most recent
STROKEAHA.107.481838v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoki, T.
Right arrow Articles by Hashimoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoki, T.
Right arrow Articles by Hashimoto, N.
Related Collections
Right arrow Aneurysm, AVM, hematoma
Right arrow Animal models of human disease
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

(Stroke. 2007;38:2337.)
© 2007 American Heart Association, Inc.


Original Contributions

Role of TIMP-1 and TIMP-2 in the Progression of Cerebral Aneurysms

Tomohiro Aoki, MD; Hiroharu Kataoka, MD, PhD; Takuya Moriwaki, MD, PhD; Kazuhiko Nozaki, MD, PhD Nobuo Hashimoto, MD, PhD

From the Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Correspondence to Hiroharu Kataoka, MD, PhD, Department of Neurosurgery, Kyoto University Graduate School of Medicine, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. E-mail kataoka{at}kuhp.kyoto-u.ac.jp

Background and Purpose— The degradation of extracellular matrix (ECM) is a hallmark of a cerebral aneurysm; however, little is known regarding the molecular mechanism leading to this change. Tissue inhibitor of matrix metalloproteinase (TIMP) regulates the ECM degradation in vascular walls by inhibiting the activity of matrix metalloproteinases (MMPs). We investigated the role of TIMPs in the progression of cerebral aneurysms in the present study.

Methods— TIMP-1 and TIMP-2 expression was examined by immunohistochemistry and quantitative RT-PCR in experimentally-induced cerebral aneurysms in rats. The incidence of aneurysmal changes in TIMP-1–/– and TIMP-2–/– mice was compared with that in the wild-type mice.

Results— TIMP-1 and TIMP-2 were expressed mainly by smooth muscle cells in aneurysmal walls. Quantitative PCR showed an increase of TIMP-1 and TIMP-2 mRNA in the early stage of aneurysm progression (form 0 to 1 month) but not in the late stage (form 1 to 3 months), whereas mRNA expression of MMP-2 and MMP-9 dramatically increased in the late stage. In both TIMP-1–/– mice and TIMP-2–/– mice, aneurysm progression was promoted with the increased enzyme activity of MMPs.

Conclusions— Our findings suggest that TIMP-1 and TIMP-2 have a protective role for the progression of cerebral aneurysms. There is an imbalance between MMPs and TIMPs in the late stage of cerebral aneurysm formation, which may be responsible for ECM degradation leading to the progression and rupture of cerebral aneurysms.


Key Words: animal model • cerebral aneurysm • matrix metalloproteinase • remodeling • tissue inhibitor of matrix metalloproteinase




This article has been cited by other articles:


Home page
StrokeHome page
T. Aoki, H. Kataoka, R. Ishibashi, K. Nozaki, and N. Hashimoto
Cathepsin B, K, and S Are Expressed in Cerebral Aneurysms and Promote the Progression of Cerebral Aneurysms
Stroke, September 1, 2008; 39(9): 2603 - 2610.
[Abstract] [Full Text] [PDF]